FGD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.823800E-01
Normal-vs-Stage2
4.076000E-01
Normal-vs-Stage3
8.508000E-01
Normal-vs-Stage4
2.953800E-01
Stage1-vs-Stage2
1.886040E-01
Stage1-vs-Stage3
7.012000E-01
Stage1-vs-Stage4
1.197410E-01
Stage2-vs-Stage3
4.986600E-01
Stage2-vs-Stage4
5.696800E-01
Stage3-vs-Stage4
4.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.201000E-01
Normal-vs-AfricanAmerican
6.554000E-01
Normal-vs-Asian
5.434600E-01
Caucasian-vs-AfricanAmerican
8.347800E-01
Caucasian-vs-Asian
9.779800E-01
AfricanAmerican-vs-Asian
8.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.207400E-01
Normal-vs-Female
4.901600E-01
Male-vs-Female
6.277400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.188200E-01
Normal-vs-Age(41-60Yrs)
2.885400E-01
Normal-vs-Age(61-80Yrs)
6.192800E-01
Normal-vs-Age(81-100Yrs)
6.635200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.471200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.067400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.351800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.672300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.743200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.776200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.818400E-01
Normal-vs-Daily Drinker
8.428600E-01
Normal-vs-Weekly Drinker
7.038200E-01
Normal-vs-Occasional Drinker
3.217600E-01
Normal-vs-Social Drinker
5.241000E-01
Non Drinker-vs-Daily Drinker
4.243400E-01
Non Drinker-vs-Weekly Drinker
7.728400E-01
Non Drinker-vs-Occasional Drinker
3.021200E-01
Non Drinker-vs-Social Drinker
5.340000E-01
Daily Drinker-vs-Weekly Drinker
7.006400E-01
Daily Drinker-vs-Occasional Drinker
9.241700E-02
Daily Drinker-vs-Social Drinker
2.505600E-01
Weekly Drinker-vs-Occasional Drinker
2.676200E-01
Weekly Drinker-vs-Social Drinker
4.859600E-01
Occasional Drinker-vs-Social Drinker
8.414200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.437600E-01
Normal-vs-Grade 2
2.355500E-02
Normal-vs-Grade 3
4.082000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.900700E-03
Grade 1-vs-Grade 3
6.228600E-04
Grade 1-vs-Grade 4
2.437600E-01
Grade 2-vs-Grade 3
4.413700E-02
Grade 2-vs-Grade 4
2.355500E-02
Grade 3-vs-Grade 4
4.082000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.275600E-01
Normal-vs-NonDiabetic
5.083600E-01
Diabetic-vs-NonDiabetic
6.284600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.696200E-01
Normal-vs-NoPancreatitis
5.711000E-01
Pancreatitis-vs-NoPancreatitis
3.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.229200E-01
Normal-vs-N1
3.983600E-01
N0-vs-N1
7.577800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.272760E-01
Normal-vs-TP53-NonMutant
9.417800E-01
TP53-Mutant-vs-TP53-NonMutant
1.47690000229517E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
